摘要
结核分枝杆菌作为最重要的传染性病原体之一,其引起的结核病已经成为全球性的社会公共卫生问题。结核分枝杆菌耐药性的发生,是引起结核病治疗失败以及结核病患者死亡的重要危险因素。耐多药结核病(MDR-TB)的出现和流行是造成结核病疫情回升的主要原因之一,并且对于结核病的控制形成了障碍。随着全球范围内对于MDR-TB的日益重视,各种预防和治疗MDR-TB的新观点和新方法不断被提出。现就近年来MDR-TB控制策略方面的研究进展予以综述。
As one of the most important infectious pathogen,mycobacterium tuberculosis,the cause of tuberculosis,has aroused global social and public health concerns.Resistance of mycobacterium tuberculosis to anti-tuberculosis drugs is an important risk factor for treatment failure and death.Multidrug-resistant tuberculosis（MDR-TB）leads to the epidemic tuberculosis recurrence,which hinders the controlling of tuberculosis.With more attentions paid to MDR-TB worldwide,new viewpoints and methods have been proposed.This paper summarizes the research advances on the controlling strategies for MDR-TB in recent years.
出处
《医学综述》
2010年第15期2241-2243,共3页
Medical Recapitulate
基金
国家科技重大专项"十一五"计划(2008ZX10003-014)
关键词
结核
耐多药性
控制
Tuberculosis
Multidrug resistance
Control
